Literature DB >> 21458249

Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction.

Petr Dubový1.   

Abstract

Wallerian degeneration is a cascade of stereotypical events in reaction to injury of nerve fibres. These events consist of cellular and molecular alterations, including macrophage invasion, activation of Schwann cells, as well as neurotrophin and cytokine upregulation. This review focuses on cellular and molecular changes distal to various types of peripheral nerve injury which simultaneously contribute to axonal regeneration and neuropathic pain induction. In addition to the stereotypical events of Wallerian degeneration, various types of nerve damage provide different conditions for both axonal regeneration and neuropathic pain induction. Wallerian degeneration of injured peripheral nerve is associated with an inflammatory response including rapid upregulation of the immune signal molecules like cytokines, chemokines and transcription factors with both beneficial and detrimental effects on nerve regeneration or neuropathic pain induction. A better understanding of the molecular interactions between the immune system and peripheral nerve injury would open the possibility for targeting these inflammatory mediators in therapeutic interventions. Understanding the pleiotropic effects of cytokines/chemokines, however, requires investigating their highly specific pathways and precise points of action.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21458249     DOI: 10.1016/j.aanat.2011.02.011

Source DB:  PubMed          Journal:  Ann Anat        ISSN: 0940-9602            Impact factor:   2.698


  70 in total

Review 1.  Peripheral nerve injury modulates neurotrophin signaling in the peripheral and central nervous system.

Authors:  Mette Richner; Maj Ulrichsen; Siri Lander Elmegaard; Ruthe Dieu; Lone Tjener Pallesen; Christian Bjerggaard Vaegter
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

2.  In vivo and systems biology studies implicate IL-18 as a central mediator in chronic pain.

Authors:  Kiran Vasudeva; Yoram Vodovotz; Nabil Azhar; Derek Barclay; Jelena M Janjic; John A Pollock
Journal:  J Neuroimmunol       Date:  2015-04-28       Impact factor: 3.478

Review 3.  Chronic Scrotal Content Pain: a Review of the Literature and Management Schemes.

Authors:  Paul J Oh; Petar Bajic; Scott D Lundy; Matthew Ziegelmann; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2021-01-15       Impact factor: 3.092

4.  Bilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain model.

Authors:  Ivana Hradilová Svízenská; Václav Brázda; Ilona Klusáková; Petr Dubový
Journal:  J Histochem Cytochem       Date:  2013-05-08       Impact factor: 2.479

5.  Analysis of the variation in low-level laser energy density on the crushed sciatic nerves of rats: a morphological, quantitative, and morphometric study.

Authors:  Eduardo Keiske Mastuda Ziago; Valéria Paula Sassoli Fazan; Mamie Mizusaki Iyomasa; Luiz Gustavo Sousa; Paula Yumi Yamauchi; Eunice Aparecida da Silva; Eduardo Borie; Ramón Fuentes; Fernando José Dias
Journal:  Lasers Med Sci       Date:  2017-01-07       Impact factor: 3.161

Review 6.  Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials.

Authors:  Ana Maria Blanco Martinez; Camila de Oliveira Goulart; Bruna Dos Santos Ramalho; Júlia Teixeira Oliveira; Fernanda Martins Almeida
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

7.  Bone morphogenetic protein 4 mediates estrogen-regulated sensory axon plasticity in the adult female reproductive tract.

Authors:  Aritra Bhattacherjee; M A Karim Rumi; Hinrich Staecker; Peter G Smith
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

8.  Deletion of Nrf2 impairs functional recovery, reduces clearance of myelin debris and decreases axonal remyelination after peripheral nerve injury.

Authors:  Linxia Zhang; Delinda Johnson; Jeffrey A Johnson
Journal:  Neurobiol Dis       Date:  2013-01-14       Impact factor: 5.996

Review 9.  [Neuropathic pain: pathophysiology, assessment, and therapy].

Authors:  C Sommer
Journal:  Schmerz       Date:  2013-12       Impact factor: 1.107

10.  Adenosine 5'-triphosphate (ATP) inhibits schwann cell demyelination during Wallerian degeneration.

Authors:  Youn Ho Shin; Hyung-Joo Chung; Chan Park; Junyang Jung; Na Young Jeong
Journal:  Cell Mol Neurobiol       Date:  2013-12-23       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.